O Brien Greene & Co. Inc Grows Holdings in The Joint Corp. (NASDAQ:JYNT)

O Brien Greene & Co. Inc increased its position in shares of The Joint Corp. (NASDAQ:JYNT) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 115,620 shares of the company’s stock after buying an additional 1,000 shares during the period. O Brien Greene & Co. Inc’s holdings in Joint were worth $1,626,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in JYNT. Price T Rowe Associates Inc. MD grew its holdings in Joint by 5.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after acquiring an additional 837 shares in the last quarter. Avondale Wealth Management grew its holdings in Joint by 15.8% during the 2nd quarter. Avondale Wealth Management now owns 22,000 shares of the company’s stock worth $309,000 after acquiring an additional 3,000 shares in the last quarter. Bard Associates Inc. grew its holdings in Joint by 4.3% during the 4th quarter. Bard Associates Inc. now owns 79,549 shares of the company’s stock worth $764,000 after acquiring an additional 3,250 shares in the last quarter. Trexquant Investment LP grew its holdings in Joint by 8.0% during the 4th quarter. Trexquant Investment LP now owns 82,686 shares of the company’s stock worth $795,000 after acquiring an additional 6,097 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its holdings in Joint by 8.9% during the 1st quarter. Russell Investments Group Ltd. now owns 90,147 shares of the company’s stock worth $1,177,000 after acquiring an additional 7,375 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Joint Price Performance

Shares of JYNT stock opened at $11.57 on Wednesday. The firm has a market cap of $173.25 million, a P/E ratio of -15.43 and a beta of 1.58. The Joint Corp. has a 1-year low of $7.31 and a 1-year high of $17.82. The firm has a fifty day moving average of $12.36 and a two-hundred day moving average of $13.22.

Joint (NASDAQ:JYNT) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Joint had a positive return on equity of 2.17% and a negative net margin of 12.00%. The company had revenue of $30.26 million for the quarter, compared to analyst estimates of $29.65 million. On average, sell-side analysts expect that The Joint Corp. will post 0.13 EPS for the current year.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.